Drugs / Sabin Monovalent Oral Polio Vaccine Type 3
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04529538 Comparator | Mar 2021 → Feb 2023 | poliomyelitis | PATH | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sabin Monovalent Oral Polio Vaccine Type 3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04529538 ↗ |
| Known as | mOPV3 | “Sabin Monovalent Oral Polio Vaccine Type 3 (mOPV3)” NCT04529538 ↗ |
| Modality | Vaccine | “Sabin monovalent vaccines” NCT04529538 ↗ |
| Route | Oral | “Sabin Monovalent Oral Polio Vaccine Type 3 (mOPV3)” NCT04529538 ↗ |